Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

SCIENTISTS investigating Alzheimer's disease have made a key breakthrough ... "Targeting this pathway may open up new avenues for treatment by either halting the toxic lipid production or ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Alzheimer's is the most common cause of dementia and researchers say their findings could lead to treatments that could slow ...

Repeated head injuries could trigger Alzheimer’s disease by awakening a dormant virus in the brain, a study suggests. Many ...

For years, researchers have debated the root cause of Alzheimer’s. Two main theories dominate the discussion. The first ...

Earlier this year, hopes for an Alzheimer's treatment breakthrough were dashed when the medicines watchdog deemed a breakthrough drug too costly for NHS use, reports the Express. Lecanemab ...

When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...

The study stated that the herpes virus can trigger the formation of tau, a protein which can form tangles in Alzheimer's ...